🕵️ Regen Biopharma Inc ($RGBP)
SEC insider & ownership activity, last 12 months · CIK 1589150 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Quick Capital, LLC | 9.9% | 13G | Sep 12, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 10, 2026 | filing ↗ |
| Auditor change (4.01) | Jul 10, 2026 | filing ↗ |
| Other events (8.01) | Jul 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 10, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Feb 4, 2026 | filing ↗ |
| Other events (8.01) | Jan 19, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jan 15, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 8, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 2, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 2, 2025 | filing ↗ |
| Other events (8.01) | Oct 2, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 2, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Sep 15, 2025 | filing ↗ |
| Material agreement (1.01) | Aug 5, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2025 | filing ↗ |
| Material agreement (1.01) | Jul 28, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Jul 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 28, 2025 | filing ↗ |